Global estimates on the number of persons across the Alzheimer's disease continuum

Cited by (900)

Items 201–300 of 900

1. Cognitive decline assessment in speakers of understudied languages
   Oula Hatahet, Florian Röser, Mohamed Lamine Seghier · 2023 · Alzheimer s & Dementia Translational Research & Clinical Interventions
2. Drug Discovery Based on Oxygen and Nitrogen (Non-)Heterocyclic Compounds Developed @LAQV–REQUIMTE/Aveiro
   Joana L. C. Sousa, Hélio M. T. Albuquerque, Artur M. S. Silva · 2023 · Pharmaceuticals
3. Trachyspermum ammi Bioactives Promote Neuroprotection by Inhibiting Acetylcholinesterase, Aβ-Oligomerization/Fibrilization, and Mitigating Oxidative Stress In Vitro
   Himadri Sharma, Hye-Won Yang, Niti Sharma, Seong Soo A. An · 2023 · Antioxidants
4. Functional Near-Infrared Spectroscopy in neurodegenerative disease: a review
   Lei Xie, Yong Liu, Yuling Gao, Jiaqi Zhou · 2024 · Frontiers in Neuroscience
5. 2024 AA criteria for Alzheimer's disease diagnosis: Mainly anchored at Aβ not tau
   Alexis Moscoso, Nicolas Villain · 2024 · Alzheimer s & Dementia
6. Deciphering the Therapeutic Efficacy and Underlying Mechanisms of Dendrobium officinale Polysaccharides in the Intervention of Alzheimer’s Disease Mice: Insights from Metabolomics and Microbiome
   Jun Fen Fu, Zhou Liang, Zihao Chen, Yiyang Zhou, Fen Xiong, Qian Liang, Hongchang Gao · 2024 · Journal of Agricultural and Food Chemistry
7. Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond
   Carl Alexander Sandhof, Heide F.B. Murray, M. Catarina Silva, Stephen J. Haggarty · 2024 · Neurotherapeutics
8. Understanding the Molecular Impact of Physical Exercise on Alzheimer’s Disease
   Alba Cantón-Suárez, Leticia Sánchez-Valdeón, Laura Bello-Corral, Maria Jose Cuevas, Brisamar Estébanez · 2024 · International Journal of Molecular Sciences
9. Sex-related differences in genetically determined Alzheimer’s disease
   Laura del Hoyo Soriano, Olivia Wagemann, Alexandre Bejanin, Johannes Levin, Juan Fortea · 2025 · Frontiers in Aging Neuroscience
10. Connections Between Cellular Senescence and Alzheimer’s Disease—A Narrative Review
    Julia Kuźniar, Patrycja Kozubek, Magdalena Czaja, Hanna Sitka, Urszula Kochman, Jerzy Leszek · 2025 · International Journal of Molecular Sciences
11. Tau in Alzheimer's disease: Shaping the future patient journey
    Catherine Jane Mummery, Christopher Chen Li-Hsian, Cristian A. Lasagna‐Reeves, Rik Ossenkoppele, Christopher C. Rowe, Douglas W. Scharre, Huali Wang, Simon Kyaga, Jeffrey L. Cummings · 2026 · The Journal of Prevention of Alzheimer s Disease
12. Motivations of patients and their care partners for visiting a memory clinic. A qualitative study
    Leonie N.C. Visser, Agnetha Diantha Fruijtier, Marleen Kunneman, Femke H. Bouwman, Niki S.M. Schoonenboom, Salka S. Staekenborg, Hilje A. Wind, Liesbeth Hempenius, Marlijn H. de Beer, Gerwin Roks et al. · 2023 · Patient Education and Counseling
13. Comparison Between Burden of Care Partners of Individuals with Alzheimer’s Disease Versus Individuals with Other Chronic Diseases
    Murat Demirbas, Julie Hviid Hahn‐Pedersen, Henrik Løvendahl Jørgensen · 2023 · Neurology and Therapy
14. Burnout among neurologists caring for patients with cognitive disorders in Spain
    Juan Fortea, Elena García-Arcelay, Guillermo García‐Ribas, Neus Canal, Jorge Mauriño · 2023 · PLoS ONE
15. Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey
    Rilès Boumali, Laureline Urli, Meriem Naïm, Feryel Soualmia, Kiyoka Kinugawa, Isabelle Petropoulos, Chahrazade El Amri · 2024 · Biochimie
16. Synthesis and Neurobehavioral Evaluation of a Potent Multitargeted Inhibitor for the Treatment of Alzheimer’s Disease
    Mohd Shahnawaz Khan, Zuber Khan, Nasimudeen R. Jabir, Sidharth Mehan, Mohd Suhail, Syed Kashif Zaidi, Torki A. Zughaibi, Mohammad Abid, Shams S. M. Tabrez · 2024 · Molecular Neurobiology
17. The Best of Two Worlds to Promote Healthy Cognitive Aging: Definition and Classification Approach of Hybrid Physical Training Interventions
    Fabian Herold, Paula Theobald, Thomas Gronwald, Navin Kaushal, Liye Zou, Eling Douwe de Bruin, Louis Bherer, Notger G. Müller · 2024 · JMIR Aging
18. A philosophy of science approach to the amyloid hypothesis of Alzheimer's disease
    Timothy P Daly · 2024 · European Journal of Neuroscience
19. Abnormal Regulation of Mitochondrial Sphingolipids during Aging and Alzheimer’s Disease
    Simone M. Crivelli, Zainuddin Quadri, Ahmed M. Elsherbini, Hemendra J. Vekaria, Patrick G. Sullivan, Wenbo Zhi, Pilar Martínez‐Martínez, Stefka D. Spassieva, Erhard Bieberich · 2024 · ASN NEURO
20. Assessing polyomic risk to predict Alzheimer's disease using a machine learning model
    Tiffany Ngai, Julian Willett, Mohammad Waqas, Lucas Fishbein, Younjung Choi, Georg Hahn, Kristina Mullin, Christoph Lange, Julian Hecker, Rudolph E. Tanzi et al. · 2024 · Alzheimer s & Dementia
21. Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
    Ze-Hu Sheng, Lanyang Wang, Ming Chen, Fuxin Zhong, Shijing Wu, Shuyu Liang, Jiaqi Song, Lihua Chen, Yingxi Chen, Shiyu Chen et al. · 2025 · Alzheimer s Research & Therapy
22. Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting
    Anders B. Wimo, Ron L. H. Handels, Kaj Blennow, Bjørn‐Eivind Kirsebom, Per Selnes, Jaka Bon, Andreja Emeršič, Fernando González‐Ortiz, Milica Gregorič Kramberger, Anders Sköldunger et al. · 2025 · Journal of Alzheimer s Disease
23. Biological mechanisms, pharmacological and pathological activities, and quality optimization of gingerols and shogaols
    Xicen Jiang · 2025 · Journal of Functional Foods
24. The role of quinoline in the development of near-infrared fluorescent probes for diagnosis of Alzheimer's disease
    Lúcia Melo, Artur M. S. Silva, Hélio M. T. Albuquerque · 2025 · European Journal of Medicinal Chemistry
25. HIF-1α-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis
    Manyu Dong, Yilun Qian, Yao Geng, Ruiyu Wang, Yu Wang, Jili Cai, Xihui Wang, Ying Huang, Yan Liu, Wentao Liu et al. · 2025 · Journal of Alzheimer s Disease
26. Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo‐controlled trials of semaglutide in participants with early‐stage symptomatic Alzheimer's disease
    Philip Scheltens, Alireza Atri, Howard Feldman, Henrik Zetterberg, Mary Sano, Peter Johannsen, Teresa León, Lars Bardtrum, Rose Jeppesen, Charlotte Thim Hansen et al. · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
27. Associations of liver function with plasma biomarkers for Alzheimer’s Disease
    Bin Zhang, Cheng Zhang, Yuye Wang, LeiAn Cheng, Yu Wang, Yanan Qiao, Dantao Peng, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Neurological Sciences
28. Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease
    Ji Eun Park, Chhabi Lal Chaudhary, Deepak Bhattarai, Kyung Bo Kim · 2024 · Journal of Medicinal Chemistry
29. Oxygen-enriching triphase platform for reliable sensing of femtomolar Alzheimer’s neurofilament lights
    Yunji Song, Hayeon Kim, Joonseok Lee, Kayoung Kim · 2024 · Biosensors and Bioelectronics
30. CoVAMPnet: Comparative Markov State Analysis for Studying Effects of Drug Candidates on Disordered Biomolecules
    Sérgio M. Marques, Petr Kouba, Anthony Legrand, Jiří Sedlář, Lucas Disson, Joan Planas-Iglesias, Zainab K. Sanusi, Antonín Kunka, Jiřı́ Damborský, Tomáš Pajdla et al. · 2024 · JACS Au
31. The role of egg-derived nutrients in Alzheimer's disease: Exploring potential benefits and biological insights
    Md Salahuddin, Ahmed A. A. Abdel‐Wareth, Ahmed K. Rashwan, Kohzy Hiramatsu, Sadanand Fulzele, Jayant Lohakare · 2024 · Food Bioscience
32. Exploring the role of mitochondrial uncoupling protein 4 in brain metabolism: implications for Alzheimer’s disease
    Simone M. Crivelli, Aisylu Gaifullina, Jean‐Yves Chatton · 2024 · Frontiers in Neuroscience
33. Protective effects of polydatin amphiphilic chitosan nanocarriers against an aluminum chloride-induced model of Alzheimer’s disease in rats: relevance to its anti-inflammatory and antioxidant effects
    Seyede Nazanin Zarneshan, Elham Arkan, Amir Kiani, Seyede Zahra Hosseini, Fatemeh Abbaszadeh, Sajad Fakhri · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
34. Sequential Proteomic Analysis Reveals the Key APOE4‐Induced Pathological and Molecular Features at the Presymptomatic Stage in Alzheimer's Disease Mice
    Wei, Pengju, Lin, Kaihua, Chen, Xuhui, Fang, Cheng, Qiu, Linhui, Hu, Jun, Chang, Junlei · 2025 · CNS Neuroscience & Therapeutics
35. Neuron-targeted caveolin-1 overexpression attenuates cognitive loss and pathological transcriptome changes in symptomatic Alzheimer’s disease models
    Dongsheng Wang, Andrei V. Chernov, Ryan Lam, Hongxia Wang, Wenxi Li, Xiaojing Li, Tiffany Duong, Shanshan Wang, Brian Patrick Head · 2025 · Signal Transduction and Targeted Therapy
36. Resting-state MRI functional connectivity as a neural correlate of multidomain lifestyle adherence in older adults at risk for Alzheimer’s disease
    Meishan Ai, Timothy P. Morris, Jiahe Zhang, Adrián Noriega de la Colina, Jennifer Tremblay‐Mercier, Sylvia Villeneuve, Susan Whitfield, Arthur F. Kramer, Maiya Rachel Geddes, Paul S. S Aisen et al. · 2023 · Scientific Reports
37. Neurophysiological correlates of altered time awareness in Alzheimer’s disease and frontotemporal dementia
    Valeria Bracca, Valentina Cantoni, Yasmine Gadola, Jasmine Rivolta, Maura Cosseddu, Rosanna Turrone, Salvatore Caratozzolo, Mónica Di Luca, Alessandro Padovani, Barbara Borroni et al. · 2023 · Neurological Sciences
38. Identifying Alzheimer Disease Dementia Levels Using Machine Learning Methods
    Md Gulzar Hussain, Shiren Ye · 2023 · Medical Research Archives
39. Consensus on rapid screening for prodromal Alzheimer’s disease in China
    Lin Huang, Qinjie Li, Yao Lu, Fengfeng Pan, Liang Cui, Ying Wang, Ya Miao, Tianlu Chen, Yatian Li, Jingnan Wu et al. · 2024 · General Psychiatry
40. Antioxidants Against Neurological Disorders
    Jasjeet Kaur Narang, Anmol Dogra, Tajpreet Kaur, Ramandeep Singh Narang, Amrit Pal Singh · 2024 · Antioxidants
41. Technical system of electroencephalography-based brain–computer interface: Advances, applications, and challenges
    Hui Yu, Qiyue Mu, Chong Liu, Shuo Wang, Jinglai Sun · 2025 · Neural Regeneration Research
42. Biomarkers in Alzheimer's disease clinical trials: 2025
    Amanda M. Leisgang Osse, Yadi Zhou, Jefferson W. Kinney, Andrew Hooyman, Ayan Sengupta, Jorge Fonseca, Aaron H. Burstein, Meriel Owen, Laura Nisenbaum, Howard M. Fillit et al. · 2026 · Alzheimer s & Dementia Translational Research & Clinical Interventions
43. Estimating the prevalence of diagnosed Alzheimer disease in England across deprivation groups using electronic health records: a clinical practice research datalink study
    Thomas P. Leahy, Alex Simpson, Cormac Sammon, Clive G. Ballard, Sandro Gsteiger · 2023 · BMJ Open
44. Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
    Sophie Edwards, Dominic Trépel, Craig William Ritchie, Julie Hviid Hahn‐Pedersen, Danielle E Robinson, Mei Sum Chan, Benjamin Bray, Alice Clark, Milana Ivkovic, Wojciech Michalak et al. · 2024 · Aging and Health Research
45. Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
    Francisco Irochima Pinheiro, Irami Araújo-Filho, Amália Cinhtia Meneses Rêgo, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci, Fausto Pierdoná Gúzen · 2024 · Ageing Research Reviews
46. Insights into amyloid precursor protein target through PPI network analysis
    Ajit Kumar · 2024 · Bioinformation
47. Mechanisms underlying LncRNA SNHG1 regulation of Alzheimer’s disease involve DNA methylation
    Hong Chen, Chun-Jie Zhang, Zhi-Ying Zhao, Yangyang Gao, Jian-Tian Zhao, Xiaoxu Li, Ming Zhang, He Wang · 2024 · Journal of Toxicology and Environmental Health
48. In a circuit necessary for cognition and emotional affect, Alzheimer's-like pathology associates with neuroinflammation, cognitive and motivational deficits in the young adult TgF344-AD rat
    Caesar M. Hernandez, Macy A. McCuiston, Kristian Davis, Yolanda Halls, Juan Pablo Carcamo Dal Zotto, Nateka L. Jackson, Lynn E. Dobrunz, Peter H. King, Lori L. McMahon · 2024 · Brain Behavior & Immunity - Health
49. From Gut Microbiota to Brain Waves: The Potential of the Microbiome and EEG as Biomarkers for Cognitive Impairment
    Mahathi Krothapalli, Lauren Buddendorff, Hariom Yadav, Nathan D. Schilaty, Shalini Jain · 2024 · International Journal of Molecular Sciences
50. Identifying older adults at risk for dementia based on smartphone data obtained during a wayfinding task in the real world
    Jonas Marquardt, Priyanka Mohan, Myra Spiliopoulou, Wenzel Glanz, Michaela Butryn, Esther Kuehn, Stefanie Schreiber, Anne Maaß, Nadine Diersch · 2024 · PLOS Digital Health
51. An endophenotype network strategy uncovers YangXue QingNao Wan suppresses Aβ deposition, improves mitochondrial dysfunction and glucose metabolism
    Xue Wang, Jinna Yang, Xiaolian Zhang, Jinyong Cai, Jieqi Zhang, Chuipu Cai, Yue Zhuo, Shuhuan Fang, Xinxin Xu, Hui Wang et al. · 2024 · Phytomedicine
52. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer's disease
    Paalki Sethi, Dr. Krishna Kumar Singh, Aparajita Dasgupta Amist, Mahendra Pratap Singh, Jitendra Kumar Sinha, Shampa Ghosh · 2024 · Elsevier eBooks
53. Blood N-glycomics reveals individuals at risk for cognitive decline and Alzheimer’s disease
    Robin Ziyue Zhou, Stefan Gaunitz, Bjørn‐Eivind Kirsebom, Britt Lundin, Marie Hellström, Alenka Jejcic, Anders Sköldunger, Anders B. Wimo, Bengt G. Winblad, Tormod Fladby et al. · 2025 · EBioMedicine
54. Diagnostic performance of actigraphy in Alzheimer’s disease using a machine learning classifier – a cross-sectional memory clinic study
    Mathias Holsey Gramkow, Andreas Brink-Kjær, Frederikke Kragh Clemmensen, Nikolai Sulkjær Sjælland, Gunhild Waldemar, Poul Jennum, Steen Gregers Hasselbalch, Kristian Steen Frederiksen · 2025 · Alzheimer s Research & Therapy
55. Uncovering Necroptosis in Alzheimer’s Disease: A Systematic Review of Evidence Across Experimental Models
    Nishi Shah, Gopal Natesan, Richa Gupta · 2025 · Cellular and Molecular Neurobiology
56. Topical Cellular/Tissue and Molecular Aspects Regarding Nonpharmacological Interventions in Alzheimer’s Disease—A Systematic Review
    Sorina Maria Aurelian, Adela Magdalena Ciobanu, Roxana Octavia Carare, Simona Isabelle Stoica, Aurelian Anghelescu, Vlad Ciobanu, Gelu Onose, Constantin Munteanu, Cristina Popescu, Ioana Andone et al. · 2023 · International Journal of Molecular Sciences
57. Cannabidiol improves the cognitive function of SAMP8 AD model mice involving the microbiota-gut-brain axis
    Bing-Qian Ma, Jianxin Jia, He Wang, Sijia Li, Zhan-Jun Yang, Xinxin Wang, Xu-Sheng Yan · 2024 · Journal of Toxicology and Environmental Health
58. Estimating prevalence of early symptomatic Alzheimer's disease in the United States
    Spargo, Drew, Zur, Richard, Lin, Pei‐Jung, Synnott, Patricia, Klein, Eric, Hartry, Ann · 2023 · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
59. Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer’s Disease-Related Risk
    Isabelle K. Gorham, Danielle Marie Reid, Jie Sun, Zhengyang Zhou, Robert C. Barber, Nicole Phillips · 2024 · Journal of Alzheimer s Disease
60. Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease
    Linus Jönsson, Milana Ivkovic, Alireza Atri, Ron L. H. Handels, Anders Gustavsson, Julie Hviid Hahn‐Pedersen, Teresa León, Mathias Lilja, Jens Gundgaard, Lars Lau Rakêt · 2024 · Alzheimer s Research & Therapy
61. Effects of home-based and telerehabilitation exercise on mental and physical health, and disease cost in people with Alzheimer’s disease: A meta-analysis
    Auwal Abdullahi, Thomson W. L. Wong, Shamay S. M. Ng · 2024 · Ageing Research Reviews
62. Deep Learning Applications in MRI-Based Detection of the Hippocampal Region for Alzheimer’s Diagnosis
    Yori Pusparani, Chih‐Yang Lin, Yih‐Kuen Jan, Fu‐Yu Lin, Ben-Yi Liau, Peter Ardhianto, Elvin Nur Furqon, John Sahaya Rani Alex, Jeetashree Aparajeeta, Chi-Wen Lung · 2024 · IEEE Access
63. A multimodal learning machine framework for Alzheimer’s disease diagnosis based on neuropsychological and neuroimaging data
    Meiwei Zhang, Qiushi Cui, Yang Lü, Weihua Yu, Wenyuan Li · 2024 · Computers & Industrial Engineering
64. Discovery of structurally intriguing diterpenoids as anti-neuroinflammatory agents from mangrove plant Excoecaria agallocha L. via inhibiting macrophage polarization and inflammasome
    Junyi Li, Mingbin Chen, Tingting Fu, Fei‐Fei Liu, Jin Liu, Congjun Xu, Jing Zhou, Yong Rao, Zhongping Jiang, Ling Huang · 2025 · Phytochemistry
65. Loneliness and Cognitive Function in Older Adults Living in Latin America: A Systematic Review
    David Camacho, Pamela Tella‐Vega, Fernando A. Wagner, Carolina Santamaría‐Ulloa, Amanda J. Lehning, Joseph J. Gallo, Carmen García‐Peña · 2025 · Archives of Medical Research
66. Association of genetic risk of Alzheimer’s disease and cognitive function in two European populations
    Biqi Wang, Lori Beth Chibnik, Seung Hoan Choi, Deborah Blacker, Anita L. DeStefano, Honghuang Lin · 2025 · Scientific Reports
67. Tailoring MAPK Pathways: New Therapeutic Avenues for Treating Alzheimer’s Disease
    Apoorv Sharma, Vandana Mehra, Vijay Kumar, Aklank Jain, Hridayesh Prakash · 2025 · Molecular Neurobiology
68. Digital biomarkers in early Alzheimer's disease from wearable or portable technology: A scoping review
    Mathias Holsey Gramkow, Helena Sophia Gleerup, Anja Hviid Simonsen, Gunhild Waldemar, Kristian Steen Frederiksen · 2026 · Journal of the Neurological Sciences
69. In-vitro and in-silico cholinesterase inhibitory activity of bioactive molecules isolated from the leaves of Andrographis nallamalayana J.L. Ellis and roots of Andrographis beddomei C.B. Clarke
    Narender Goel, Aakriti Garg, Chennuru Nagendra, Araveeti Madhusudhana Reddy, Raju Biswas, Ramalingam Natarajan, Parasuraman Jaisankar · 2023 · Journal of Molecular Structure
70. Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation
    Sharif H. Arar, Md. Anzarul Haque, Nemil N. Bhatt, Yingxin Zhao, Rakez Kayed · 2024 · ACS Chemical Neuroscience
71. On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use
    Robin Ziyue Zhou, Anders B. Wimo, Bengt G. Winblad · 2024 · The Journal of Prevention of Alzheimer s Disease
72. Donepezil-based combination therapy for Alzheimer’s disease and related neuropathies
    Bidemi Emmanuel Ekundayo, Tajudeen Olabisi Obafemi, Olusola Bolaji Adewale, Babatunji Emmanuel Oyinloye · 2023 · Comparative Clinical Pathology
73. Structurally diverse brefeldin A derivatives as potent and selective acetylcholinesterase inhibitors from an endophytic fungus Penicillium brefeldianum F4a
    Yan Bai, Duo Ren, Xinlei Xue, Weixian Gao, Jiangchun Hu, Huaqi Pan · 2023 · Arabian Journal of Chemistry
74. Differential Study of Retinal Thicknesses in the Eyes of Alzheimer’s Patients, Multiple Sclerosis Patients and Healthy Subjects
    Elena García‐Martín, Daniel Jimeno-Huete, Francisco J. Dongil-Moreno, Luciano Boquete, Eva María Sánchez‐Morla, Juan Manuel Miguel, Almudena López-Dorado, Elisa Viladés, Maria I. Fuertes, Ana Pueyo et al. · 2023 · Biomedicines
75. Novel Alzheimer's disease subtypes based on functional brain connectivity in human connectome project
    Jinhua Sheng, Xin Yu, Qiao Zhang, Ze Xiao Yang, Luyun Wang, Qian Zhang, Binbing Wang · 2024 · Scientific Reports
76. Lessons from the physiological role of guanosine in neurodegeneration and cancer: Toward a multimodal mechanism of action?
    Carla I. Tasca, Mariachiara Zuccarini, Patrizia Di Iorio, Francisco Ciruela · 2024 · Purinergic Signalling
77. Machine learning applications in Alzheimer’s disease research: a comprehensive analysis of data sources, methodologies, and insights
    Zahra Rezaie, Yaser Mike Banad · 2024 · International Journal of Data Science and Analytics
78. Impaired glymphatic clearance is an important cause of Alzheimer’s disease
    Iyawnna Hazzard, Maryann Batiste, Tianyu Luo, Cyrus Cheung, Forshing Lui · 2024 · Exploration of Neuroprotective Therapy
79. A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease
    Emma Ehn, Jesper Eisfeldt, José Miguel Laffita‐Mesa, Håkan Thonberg, Jacqueline Schoumans, Anne M. Portaankorva, Matti H. Viitanen, Anna Lindstrand, Inger Nennesmo, Caroline Graff · 2025 · Scientific Reports
80. Monitoring Acidification Preceding Aβ Deposition in Alzheimer's Disease
    Guannan Zhu, Hong Zhang, Ruoxi Xie, Muhammad Rizwan Younis, Shengxiang Fu, Xiaoze Wang, Beibei Liu, Kun Li, Su Lui, Min Cong Wu · 2025 · Advanced Healthcare Materials
81. Celastrol Ameliorated Alzheimer’s Disease in Mice by Enhancing TBX21/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation
    Fanfan Cao, Pan Zhang, Yongbin Chi, Ying Wang, Limin Xu, Denghai Zhang · 2025 · Neurochemical Research
82. Exploring the Multi‐Target Effects of Valeriana officinalis in Alzheimer's Disease: a Network Pharmacology Approach
    Vishnu Kumar Malakar, Dhanabal Palanisamy, Antony Justin, Dhritiman Roy, Kamal Kant, Rafa Almeer, Kavya S. Keremane, Chandi C. Malakar · 2025 · ChemistrySelect
83. Relationship between endocrine disruptors and neurodegenerative diseases: Systematic review and meta-analysis
    Chengxing Wang, Jie Xu, Kai Pan, Yuzhu Xu, Jie Yu · 2025 · iScience
84. Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S.
    Soeren Mattke, Jiahe Chen, Mark Hanson, Kim G. Johnson, Cara Leahy, David A. Merrill, Victoria Shada, Jorge G. Ruiz · 2025 · The Journal of Prevention of Alzheimer s Disease
85. Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer’s Disease: Synthesis of Evidence from Observational and Interventional Trials
    Susan R. Abushakra, Pudugramam Murali Doraiswamy, John A. Hey, Duygu Tosun, Frederik Barkhof, Jerome A. Barakos, Jeffrey R. Petrella, J. Patrick Kesslak, Aidan Power, Marwan Noel Sabbagh et al. · 2025 · CNS Drugs
86. Acetylcholinesterase inhibitory activity of Ferula plants and their potential for treatment of Alzheimer’s disease
    Seyyed Majid Bagheri, Mohammad Allahtavakoli, Alireza Moradi · 2023 · Journal of Complementary and Integrative Medicine
87. Cognitive impairment in type 2 diabetes mellitus: prospects for the use of metformin
    N.V. Pashkovska · 2023 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
88. Atomic Force Microscopy Applied to the Study of Tauopathies
    Maria do Socorro do Nascimento Amorim, Álefe Roger Silva França, Ralph Santos‐Oliveira, Jonas Rodrigues Sanches, Thamys Marinho Melo, Bruno Pinto, Leandro R.S. Barbosa, Luciana Magalhães Rebêlo Alencar · 2024 · ACS Chemical Neuroscience
89. Clinical Update on an Anti-Alzheimer Drug Candidate CT1812: A Sigma-2 Receptor Antagonist
    Guramrit Kaur, Zahid Ahmad Dar, Ankit Bajpai, Ranjit Singh, Ranju Bansal · 2024 · Clinical Therapeutics
90. A glycan biomarker predicts cognitive decline in amyloid- and tau-negative patients
    Robin Ziyue Zhou, Frida Duell, Michael Axenhus, Linus Jönsson, Bengt G. Winblad, Lars O. Tjernberg, Sophia Schedin‐Weiss · 2024 · Brain Communications
91. Risk of Alzheimer’s disease and genetically predicted levels of 1400 plasma metabolites: a Mendelian randomization study
    Di Cao, Yini Zhang, Shaobo Zhang, Jun Li, Qiguang Yang, Ping Wang · 2024 · Scientific Reports
92. Alzheimer’s Disease Detection in Various Brain Anatomies Based on Optimized Vision Transformer
    Faisal Mehmood, Asif Mehmood, Taeg Keun Whangbo · 2025 · Mathematics
93. A Study on Machine Learning Models in Detecting Cognitive Impairments in Alzheimer’s Patients Using Cerebrospinal Fluid Biomarkers
    Tiwari, Vivek K., Indic, Premananda, Tabassum, Shawana · 2024 · American Journal of Alzheimer's Disease & Other Dementias®
94. Evaluating the effect of extra-cerebral off-target binding in [F-18]MK6240 PET scans in early-stage Alzheimer’s disease
    Andrew K McVea, Alexandra H DiFilippo, Max McLachlan, Matthew D. Zammit, Barbara B. Bendlin, Sterling C. Johnson, Tobey J. Betthauser, Bradley T. Christian · 2024 · Imaging Neuroscience
95. Unraveling Gender Fairness Analysis in Deep Learning Prediction of Alzheimer’s Disease
    Solveig Kristina Hammonds, Trygve Eftestøl, Ketil Oppedal, Álvaro Fernández-Quilez · 2024 · International Conference on Applied Artificial Intelligence (ICAPAI)
96. Tannins-enriched fraction of TeMac™ protects against aluminum chloride induced Alzheimer's disease-like pathology by modulating aberrant insulin resistance and alleviating oxidative stress in diabetic rats
    Bruno Dupon Akamba Ambamba, Fils Armand Ella, Dany Joël Ngassa Ngoumen, Ruth Edwige Kemadjou Dibacto, Agwe Nicoline Injoh, Florine Essouman Mbappe, Martin Fonkoua, Damaris Enyegue Mandob, Judith Laure Ngondi · 2024 · Journal of Ethnopharmacology
97. Impact of Coconut Oil and Its Bioactive Metabolites in Alzheimer’s Disease and Dementia: A Systematic Review and Meta-Analysis
    Duaa Abdullah Bafail, Abrar Bafail, Norah Alshehri, Noura Hamdi Yousef Alhalees, Ahmad Bajarwan · 2024 · Diseases
98. Experiences from Clinical Research and Routine Use of Florbetaben Amyloid PET—A Decade of Post-Authorization Insights
    Aleksandar Jovalekic, Santiago Bullich, Núria Roé-Vellvé, Guilherme Domingues Kolinger, Lorelei R. Howard, Floriana Elsholz, Mariana Lagos‐Quintana, Beatriz Blanco-Rodriguez, Esther Pérez-Martínez, Rossella Gismondi et al. · 2024 · Pharmaceuticals
99. Blockade of A2AR improved brain perfusion and cognitive function in a mouse model of Alzheimer’s disease
    Mariana Sayuri Berto Udo, Julia Zaccarelli‐Magalhães, Garrett A. Clemons, Cristiane Teresinha Citadin, Julia Langman, Drew James Smith, Luiz Henrique Matuguma, Vesna Tešić, Hung Wen Lin · 2025 · GeroScience
100. Online Communities as a Support System for Alzheimer Disease and Dementia Care: Large-Scale Exploratory Study
     Sidharth Kaliappan, Chunyu Liu, Yoshee Jain, Ravi Karkar, Koustuv Saha · 2025 · JMIR Aging